Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions.

MLA

Sikiric, Predrag, et al. “Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions.” Pharmaceuticals (14248247), vol. 16, no. 7, July 2023, p. 1052. EBSCOhost, https://doi.org/10.3390/ph16071052.

APA

Sikiric, P., Kokot, A., Kralj, T., Zlatar, M., Masnec, S., Lazic, R., Loncaric, K., Oroz, K., Sablic, M., Boljesic, M., Antunovic, M., Sikiric, S., Strbe, S., Stambolija, V., Beketic Oreskovic, L., Kavelj, I., Novosel, L., Zubcic, S., Krezic, I., & Skrtic, A. (2023). Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions. Pharmaceuticals (14248247), 16(7), 1052. https://doi.org/10.3390/ph16071052

Chicago

Sikiric, Predrag, Antonio Kokot, Tamara Kralj, Mirna Zlatar, Sanja Masnec, Ratimir Lazic, Kristina Loncaric, et al. 2023. “Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions.” Pharmaceuticals (14248247) 16 (7): 1052. doi:10.3390/ph16071052.